Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.865 USD | +1.78% | -3.90% | +99.60% |
05-23 | Transcript : Ventyx Biosciences, Inc. Presents at UBS Obesity Therapeutics Day, May-23-2024 12:00 PM | |
05-16 | Ventyx Biosciences Appoints Matthew Moore as Chief Operating Officer; Shares Rise | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
337M | - | - | - | - | - | |
118B | ||||||
106B | ||||||
24.28B | - | |||||
21.96B | - | |||||
18.16B |